On their own, GLP-1 drugs generally have a lower risk of hypoglycemia because they increase insulin in a glucose-dependent way
Nature 620 , 839848 (2023)
In plain terms, it is interesting because it touches multiple systems the body uses when tissue is under stress
Specifically, GLP-1 medications: Slow stomach emptying, helping people feel full sooner and stay full longer Reduce appetite and food cravings by acting on areas of the brain involved in hunger and satiety Support blood sugar control by improving insulin release after meals and reducing excess sugar production by the liver Together, these effects make it easier for many people to eat smaller portions, feel satisfied and maintain healthier habits over time
Collectively, these untargeted metabolomic analyses indicate subtle but biologically relevant metabolic differences between ASD and control groups, characterized by increased variability and pathway-level alterations rather than complete global separation
Comparative effectiveness of GLP-1 receptor agonists on glycemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis
&srotate=0)
